ZSTK Share Price Performance
US$8.90
-17.04 (-65.68%)
19.1% undervalued intrinsic discount
US$11.00
Fair Value
Price US$8.90
AnalystConsensusTarget US$11.00
Fair ValueUS$11.00
Share Pricen/a
ZeroStack Corp. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
ZSTK Community Narratives
AN
Fair Value US$11 19.1% undervalued intrinsic discount
US Cannabis And European Beverage Markets Will Create Opportunities
1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
US Cannabis And European Beverage Markets Will Create Opportunities
Key Takeaways Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry. Expansion into the infused beverage market and European operations are expected to drive revenue growth and improve profit margins through innovation and strategic partnerships.Read more
57
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
US$11
19.1% undervalued intrinsic discount
Fair Value
Profit Margin
4.02%
Future PE
N/A
Price in 2029
US$0
Trending Discussion
Recently Updated Narratives
AN
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Fair Value: US$11 19.1% undervalued intrinsic discount
7 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
ZeroStack Corp. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -47.48
- 4.62%
- -323.49%
- 75.8%
About ZSTK
- Founded
- 2019
- Employees
- 70
- CEO
- WebsiteView website
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
